Salim Hayek is a Cardiology physician. ClinicalTrials.gov lists 10 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
301 University Blvd
Galveston, TX 775555302
Telephone
409-772-1011Provider last certified this registry record 17 Mar 2026.
Clinical trials
- Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block
Sponsor: University Hospitals Cleveland Medical Center
- Patient Preference and Long-term Outcomes in Persistent Spinal Pain Syndrome: A Prospective Study Comparing Spinal Cord Stimulation to Intrathecal Drug Delivery.
Sponsor: University Hospitals Cleveland Medical Center
- Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
Sponsor: University Hospitals Cleveland Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20253 payments
- Eli Lilly and CompanyProgram year20251 payment
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79%Statin18.7%Atorvastatin Calcium68%Rosuvastatin Calcium32%Part D≥90 patientsBeta blocker11.9%Bisoprolol Fumarate58%Metoprolol Succinate43%Part D≥47 patients+ 12 more classes in this area
Blood & clotting
12.2%Factor Xa inhibitor8.8%Eliquis85%Xarelto15%Part D<11 patientsP2Y12 inhibitor3.3%Clopidogrel100%Part D≥23 patientsMetabolism & gastrointestinal
7.6%SGLT2 inhibitor7.6%Farxiga61%Jardiance39%Part D≥24 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2024 per NIH RePORTER. The latest:
- Role of SuPAR in the Intersection between Cardiovascular and Kidney Disease
University of Texas Med Br Galveston
FY2024$439,526R01HL153384
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”